CBU
GH icon

CIBC Bancorp USA’s Guardant Health GH Stock Holding History

CIBC Bancorp USA’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
8,578
+402
+5% +$43.7K ﹤0.01% 1035
2026
Q1 		$755K Buy
+8,176
New +$821K ﹤0.01% 1111
2025
Q3 		$796K Buy
+12,734
New +$693K ﹤0.01% 722

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CIBC Bancorp USA's GH Position: Q2 2026 in Review

CIBC Bancorp USA increased its Guardant Health (GH) stake by 4.9% in Q2 2026, buying an estimated $43.7K and bringing the position to 8,578 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

CIBC Bancorp USA first reported a position in GH in Q3 2025 and has held it in 3 quarters since. 550 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • CIBC Bancorp USA held 8,578 shares of Guardant Health worth $1.29M as of Q2 2026.
  • CIBC Bancorp USA bought 402 Guardant Health shares in Q2 2026, an estimated $43.7K.
  • Guardant Health made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1035 holding.
  • CIBC Bancorp USA first reported a position in Guardant Health in Q3 2025 and has held it in 3 quarters since.
  • 550 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.